Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Single-Use Bioreactors Market by Product, Type, Cell Type, Molecule, Process Mode, Application, Competition, Region - Global Forecast to 2031

globenewswire.com
AMGN While not explicitly mentioned, Amgen is a major player in the biotechnology sector which benefits from the growth in monoclonal antibody and cell and gene therapy manufacturing, areas highlighted in the article. DHR Danaher Corporation is listed as an active company in the single-use bioreactors market, indicating potential benefit from the market's projected growth. TMO Thermo Fisher Scientific Inc. is identified as a company active in the single-use bioreactors market, suggesting it could benefit from the market's expansion. AVT Avantor, Inc. is mentioned as a participant in the single-use bioreactors market, implying potential gains from the sector's projected growth. RGEN Repligen Corporation is listed as an active company in the single-use bioreactors market, suggesting it is positioned to benefit from the market's projected growth. PH Parker Hannifin Corporation is named as a company active in the single-use bioreactors market, indicating potential benefit from the market's expansion. ENTG Entegris is mentioned as a participant in the single-use bioreactors market, suggesting it could gain from the sector's projected growth. CC Corning Incorporated is listed as an active company in the single-use bioreactors market, indicating potential benefit from the market's projected growth. ESQ Esco Lifesciences Group is mentioned as a market participant in single-use bioreactors, suggesting potential gains from the sector's projected growth.

Single-Use Bioreactors Market by Product, Type, Cell Type, Molecule, Process Mode, Application, Competition, Region - Global Forecast to 2031 Dublin, Sept. 15, 2026 (GLOBE NEWSWIRE) -- "Single-Use Bioreactors Market by Product, Type, Cell Type, Molecule, Process Mode, Application, Competition, Region - Global Forecast to 2031" has been added to ResearchAndMarkets.com's offering.

The global single-use bioreactors market is projected to increase from an estimated USD 5.43 billion in 2026 to USD 9.58 billion by 2031, registering a compound annual growth rate of 12.0% during the forecast period.

Market growth is being driven by expanding biologics and biosimilar production, rising vaccine manufacturing, increased outsourcing to contract development and manufacturing organizations (CDMOs), and broader adoption of flexible bioprocessing technologies. Growing use of single-use systems in monoclonal antibody, recombinant protein, viral vector, and cell and gene therapy manufacturing is also accelerating demand.

Lower capital requirements, reduced cleaning-validation needs, faster product changeovers, and compatibility with multiproduct facilities are strengthening the business case for single-use bioreactors. These operational benefits are particularly important as pharmaceutical and biotechnology companies expand flexible manufacturing capacity and adopt batch, fed-batch, perfusion, and intensified bioprocessing strategies.

Bioproduction Led the Market by Application in 2025

The bioproduction segment accounted for the largest share of the global single-use bioreactors market in 2025. Single-use platforms are extensively deployed in the clinical and commercial production of monoclonal antibodies, vaccines, recombinant proteins, biosimilars, viral vectors, and other biologics.

The segment's leadership is supported by increasing biologics demand, expansion of global manufacturing capacity, and adoption of scalable single-use platforms by pharmaceutical and biotechnology companies and CDMOs. Reduced contamination risk, shorter turnaround times, and support for batch, fed-batch, and perfusion processes further reinforce the role of these systems in bioproduction.

Monoclonal Antibodies Accounted for the Largest Molecule-Type Share

By molecule type, the market covers monoclonal antibodies, vaccines, cell and gene therapy, and therapeutic proteins and peptides. The monoclonal antibodies segment held the largest market share in 2025, reflecting the substantial number of approved therapies, extensive development pipelines, and continued additions to commercial manufacturing capacity.

Monoclonal antibody manufacturing requires scalable, tightly controlled mammalian cell-culture processes, creating sustained demand for stirred-tank single-use bioreactors, bags, assemblies, sensors, and fluid-management components. Compatibility with batch, fed-batch, and intensified processing supports continued adoption among pharmaceutical companies, biotechnology organizations, and CDMOs.

Asia Pacific Expected to Record the Highest CAGR Through 2031

The market is analyzed across North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Asia Pacific is expected to register the fastest growth from 2026 to 2031, driven by increasing biologics and biosimilar output, vaccine manufacturing, CDMO capacity, and investment in domestic biopharmaceutical infrastructure.

China, India, Japan, South Korea, and Australia are strengthening upstream processing capabilities through new facilities, capacity expansions, and broader deployment of modular and flexible production technologies. Government support for localized manufacturing and expanding cell and gene therapy activity are also contributing to regional demand.

Market Drivers, Opportunities, Restraints, and Challenges

Competitive Landscape

Companies active in the single-use bioreactors market include Sartorius AG (Germany), Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Avantor, Inc. (US), Repligen Corporation (US), Getinge AB (Sweden), Eppendorf SE (Germany), Parker Hannifin Corporation (US), Entegris (US), Saint-Gobain (France), Corning Incorporated (US), Lonza (Switzerland), TECNIC Process Equipment Manufacturing, S.L. (Spain), ZACROS Corporation (Japan), Adolf Kuhner AG (Switzerland), OmniBRx Biotechnologies Pvt Ltd. (India), New Horizon Biotechnology, Inc. (US), PBS Biotech, Inc. (US), bbi-biotech GmbH (Germany), and ABEC, Inc. (US).

Other market participants include Esco Lifesciences Group (US), Distek, Inc. (US), SATAKE MultiMix Corporation (Japan), Cell Culture Company, LLC (US), MicroDigital Co., Ltd. (South Korea), BIONET (Spain), Meissner Filtration Products, Inc. (US), Solida Biotech GmbH (Germany), G&G Technologies, Inc. (US), PharmNXT Biotech (India), and Tofflon Life Science Co., Ltd. (China).

The competitive assessment examines company market shares, business overviews, product portfolios, growth strategies, and product offerings. It also evaluates collaborations, partnerships, facility expansions, agreements, acquisitions, product launches, investments, and other recent single-use bioreactor industry developments.

Research Coverage

The report categorizes the single-use bioreactors market across the following segments:

The research assesses market size, segment-level growth opportunities, product development and innovation, newly launched products, attractive regional markets, untapped geographies, investments, and diversification strategies. It also provides detailed analysis of the drivers, restraints, opportunities, and challenges influencing market expansion.

Primary Research Profile

Key Benefits of the Market Report

The report provides a comprehensive view of the single-use bioreactors market, including current market size, forecasts through 2031, emerging growth opportunities, regional prospects, technology trends, and competitive positioning. Buyers receive in-depth profiles of major market participants, analysis of recent developments and strategic initiatives, and insight into product innovation, market development, geographic expansion, and investment activity across the global bioprocessing industry.

Key Attributes:

Key Topics Covered:

Market Dynamics Drivers

Challenges

Case Studies Industry Trends Opportunities

Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/phux28

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.